| Literature DB >> 22759492 |
Marike M Leijs1, Gavin W ten Tusscher, Kees Olie, Tom van Teunenbroek, Wim M C van Aalderen, Pim de Voogt, Tom Vulsma, Alena Bartonova, Martin Krayer von Krauss, Claudia Mosoiu, Horacio Riojas-Rodriguez, Gemma Calamandrei, Janna G Koppe.
Abstract
BACKGROUND: Polychlorinated dioxins and -furans (PCDD/Fs) and polychlorinated-biphenyls (PCBs) are environmental toxicants that have been proven to influence thyroid metabolism both in animal studies and in human beings. In recent years polybrominated diphenyl ethers (PBDEs) also have been found to have a negative influence on thyroid hormone metabolism. The lower brominated flame retardants are now banned in the EU, however higher brominated decabromo-diphenyl ether (DBDE) and the brominated flame retardant hexabromocyclododecane (HBCD) are not yet banned. They too can negatively influence thyroid hormone metabolism. An additional brominated flame retardant that is still in use is tetrabromobisphenol-A (TBBPA), which has also been shown to influence thyroid hormone metabolism.Influences of brominated flame retardants, PCDD/F's and dioxin like-PCBs (dl-PCB's) on thyroid hormone metabolism in adolescence in the Netherlands will be presented in this study and determined if there are reasons for concern to human health for these toxins. In the period 1987-1991, a cohort of mother-baby pairs was formed in order to detect abnormalities in relation to dioxin levels in the perinatal period. The study demonstrated that PCDD/Fs were found around the time of birth, suggesting a modulation of the setpoint of thyroid hormone metabolism with a higher 3,3', 5,5'tetrathyroxine (T4) levels and an increased thyroid stimulating hormone (TSH). While the same serum thyroid hormone tests (- TSH and T4) were again normal by 2 years of age and were still normal at 8-12 years, adolescence is a period with extra stress on thyroid hormone metabolism. Therefore we measured serum levels of TSH, T4, 3,3',5- triiodothyronine (T3), free T4 (FT4), antibodies and thyroxine-binding globulin (TBG) in our adolescent cohort.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22759492 PMCID: PMC3388438 DOI: 10.1186/1476-069X-11-S1-S10
Source DB: PubMed Journal: Environ Health ISSN: 1476-069X Impact factor: 5.984
Dioxin, dl-PCB and PBDE exposure
| Mean | Range | Standard deviation | 95% confidence interval | |
|---|---|---|---|---|
| Prenatal dioxin (PCDD/F) exposure ITEQ (pg/g lipid in breastmilk), n=32 | 32.6 | 9.05-88.8 | 64.3 | 25.9-38.5 |
| Lactational dioxin (PCDD/F) exposure ITEQ (absolute quantity in ng), n=32 | 66.5 | 4.34-279 | 64.3 | 43.3-89.6 |
| Current serum dioxin (PCDD/F) WHO-TEQ (pg/g lipid in serum), n=27 | 2.2 | 0.4-6.1 | 1.6 | 1.6-2.8 |
| Current serum dl-PCBs WHO-TEQ (pg/g lipid) | 2.2 | 0.04-7.8 | 2.0 | 1.4-3.0 |
| Current serum PBDE (ng/g lipid) n=17* | 10.5 | 4.9-22.1 | 4.6 | 8.2-12.9 |
Means, ranges, standard deviation and 95% confidence interval of the exposure to Dioxins, PCBs and PBDE’s.
*Current serum PBDE levels is calculated with exclusion of the outlier (73.6 ng/g lipids)
Thyroid hormone metabolism parameters
| Mean | Range | Standard deviation | 95% confidence interval | |
|---|---|---|---|---|
| Free thyroxin (FT4) pmol/L | 14.7 | 11.8-20.8 | 2.5 | 13.7-15.6 |
| Triiodothyronin (T3) nmol/L | 2.6 | 2.1-3.5 | 0.4 | 2.5-2.7 |
| Thyroxin (T4) nmol/L | 108.6 | 75.0-165.0 | 22.2 | 100.1-117.1 |
| Thyroxin-binding globulin (TBG) mg/L | 361.4 | 220-650 | 96.7 | 324.6-398.6 |
| Thyroid stimulating hormone (TSH) mU/L | 1.75 | 0.42-4.5 | 0.98 | 1.38-2.12 |
Thyroid hormone metabolism parameters, means, ranges, standard deviation and 95% confidence interval.
Reference intervals: FT4: 9-22 ρmol/L, T4: 70-140nmol/L, T3: 1.2-3.0 nmol/L, TBG: 7-17 mg/L, TSH: 0.5-5.7 mU/L.
Figure 1Serum dl-PCBs and T3 levels (P=0.047) in the individuals at the age of 14-18 years Serum dl-PCBs and T3 levels (P=0.047) in the individuals at the age of 14-18 years
Figure 2Serum BDE-99 levels and T3 (P=0.003) in the individuals of the cohort at the age of 14-18 years. Serum BDE-99 levels and T3 (P=0.003) in the individuals of the cohort at the age of 14-18 years.